PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference
To access the live and subsequently archived webcast of the presentation, go to the Company's website at http://www.pdl.com and go to the Investor Relations section and select "Events & Presentations." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.
We seek to provide a significant return for our stockholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotechnology, pharmaceutical and medical device industries. In 2012, we began providing alternative sources of capital through royalty monetizations and debt facilities, and in 2016, we began acquiring commercial-stage products and launching specialized companies dedicated to the commercialization of these products. To date, we have consummated seventeen of such transactions, of which nine are active and outstanding. We have one debt transaction outstanding, representing deployed of
View original content with multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-present-at-the-hc-wainwright-20th-annual-global-investment-conference-300704626.html
PDL BioPharma, Inc., Peter Garcia, CFO, 775-832-8500, Peter.firstname.lastname@example.org; LHA Investor Relations, Jody Cain, SVP, 310-691-7100, email@example.com